STAT5 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "STAT5" in French language version.

Last modified: 13:45:04, 14 July 2026 (UTC)

Ref.Un. Ref.Website

Global rank French rank

1611doi.org

2^nd place

3^rd place

1411nih.gov

5^th place

11^th place

21endocrinology-journals.org

low place

21jimmunol.org

low place

8,332^nd place

doi.org (Global: 2^nd place; French: 3^rd place)

dx.doi.org

« Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation », Cytokine Growth Factor Rev., vol. 10, n^o 2,‎ juin 1999, p. 131–57 (PMID 10743504, DOI 10.1016/S1359-6101(99)00011-8)
« STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells », EMBO J., vol. 18, n^o 17,‎ septembre 1999, p. 4754–65 (PMID 10469654, PMCID 1171548, DOI 10.1093/emboj/18.17.4754)
« Signal transducer and activator of transcription 5A/B in prostate and breast cancers », Endocr. Relat. Cancer, vol. 15, n^o 2,‎ juin 2008, p. 367–90 (PMID 18508994, DOI 10.1677/ERC-08-0013, lire en ligne)
« Inhibitors of Stat5 protein signalling », MedChemComm, vol. 3, n^o 1,‎ janvier 2012, p. 22 (DOI 10.1039/C1MD00175B)
« Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2 », Nat. Immunol., vol. 12, n^o 12,‎ décembre 2011, p. 1212–20 (PMID 22037603, PMCID 3233979, DOI 10.1038/ni.2136)
« Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells », Nat. Med., vol. 2, n^o 5,‎ mai 1996, p. 561–6 (PMID 8616716, DOI 10.1038/nm0596-561)
« A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo », Blood, vol. 99, n^o 11,‎ juin 2002, p. 3885–91 (PMID 12010785, DOI 10.1182/blood.V99.11.3885)
« CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients », Leukemia, vol. 23, n^o 8,‎ août 2009, p. 1441–5 (PMID 19295546, DOI 10.1038/leu.2009.50)
« Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells », J. Immunol., vol. 171, n^o 8,‎ octobre 2003, p. 3919–27 (PMID 14530308, DOI 10.4049/jimmunol.171.8.3919, lire en ligne)
« Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma », Oncol. Rep., vol. 20, n^o 4,‎ octobre 2008, p. 873–8 (PMID 18813829, DOI 10.3892/or_00000085)
« Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity », J. Med. Chem., vol. 55, n^o 3,‎ février 2012, p. 1047–55 (PMID 22148584, DOI 10.1021/jm200720n)

endocrinology-journals.org (Global: low place; French: low place)

erc.endocrinology-journals.org

« Signal transducer and activator of transcription 5A/B in prostate and breast cancers », Endocr. Relat. Cancer, vol. 15, n^o 2,‎ juin 2008, p. 367–90 (PMID 18508994, DOI 10.1677/ERC-08-0013, lire en ligne)

jimmunol.org (Global: low place; French: 8,332^nd place)

« Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells », J. Immunol., vol. 171, n^o 8,‎ octobre 2003, p. 3919–27 (PMID 14530308, DOI 10.4049/jimmunol.171.8.3919, lire en ligne)

nih.gov (Global: 5^th place; French: 11^th place)

ncbi.nlm.nih.gov

« Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation », Cytokine Growth Factor Rev., vol. 10, n^o 2,‎ juin 1999, p. 131–57 (PMID 10743504, DOI 10.1016/S1359-6101(99)00011-8)
« STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells », EMBO J., vol. 18, n^o 17,‎ septembre 1999, p. 4754–65 (PMID 10469654, PMCID 1171548, DOI 10.1093/emboj/18.17.4754)
« Signal transducer and activator of transcription 5A/B in prostate and breast cancers », Endocr. Relat. Cancer, vol. 15, n^o 2,‎ juin 2008, p. 367–90 (PMID 18508994, DOI 10.1677/ERC-08-0013, lire en ligne)
« Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2 », Nat. Immunol., vol. 12, n^o 12,‎ décembre 2011, p. 1212–20 (PMID 22037603, PMCID 3233979, DOI 10.1038/ni.2136)
« Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia », Oncogene, vol. 13, n^o 2,‎ juillet 1996, p. 247–54 (PMID 8710363)
« Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells », Nat. Med., vol. 2, n^o 5,‎ mai 1996, p. 561–6 (PMID 8616716, DOI 10.1038/nm0596-561)
« A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo », Blood, vol. 99, n^o 11,‎ juin 2002, p. 3885–91 (PMID 12010785, DOI 10.1182/blood.V99.11.3885)
« CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients », Leukemia, vol. 23, n^o 8,‎ août 2009, p. 1441–5 (PMID 19295546, DOI 10.1038/leu.2009.50)
« Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells », J. Immunol., vol. 171, n^o 8,‎ octobre 2003, p. 3919–27 (PMID 14530308, DOI 10.4049/jimmunol.171.8.3919, lire en ligne)
« Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma », Oncol. Rep., vol. 20, n^o 4,‎ octobre 2008, p. 873–8 (PMID 18813829, DOI 10.3892/or_00000085)
« Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity », J. Med. Chem., vol. 55, n^o 3,‎ février 2012, p. 1047–55 (PMID 22148584, DOI 10.1021/jm200720n)